Gain Therapeutics GANX
NASDAQ GANX
$1.26 -0.03 (-2.33%)
At close: Oct 23, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Return on Invested Capital [ROIC] (2021 - 2026)

Updated

Gain Therapeutics' Return on Invested Capital [ROIC] was -148.27% in Q2 2026, up 184.89 percentage points from -333.16% a year earlier but down 30.15 percentage points from the prior quarter.

Analysis

Gain Therapeutics (GANX) Return on Invested Capital [ROIC] (2021 - 2026) Analysis & Trends

For FY2025, Return on Invested Capital [ROIC] at Gain Therapeutics came in at -139.93%, up 54.59 percentage points from FY2024.

  • Return on Invested Capital [ROIC] shows a four-year change of -74.79 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Invested Capital [ROIC] was -194.52% in FY2024 (-58.12 pp), -136.40% in FY2023 (-71.75 pp), -64.65% in FY2022 (+0.49 pp) and -65.14% in FY2021.
  • Quarterly Return on Invested Capital [ROIC] has moved between -335.37% (Q3 2025) and -30.45% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Invested Capital [ROIC] has increased for three straight quarters, with an average year-over-year change of +10.92 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was Q2 2026 (a gain of 184.89 percentage points); the worst was Q3 2023 (a drop of 164.73 percentage points).
  • Per Business Quant data, GANX's Return on Invested Capital [ROIC] in the three quarters before Q2 2026 was -118.12% (Q1 2026), -147.91% (Q4 2025) and -335.37% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.57%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 18.68%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 3.56%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 34.87%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 23.26%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 14.33%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -5.97%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 13.44%
10 Gain Therapeutics 54.61 Mn -4.68 Mn - -148.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.27%
Mar 31, 2026 -118.12%
Dec 31, 2025 -147.91%
Sep 30, 2025 -335.37%
Jun 30, 2025 -333.16%
Mar 31, 2025 -290.91%
Dec 31, 2024 -236.88%
Sep 30, 2024 -197.71%
Jun 30, 2024 -204.03%
Mar 31, 2024 -191.97%
Dec 31, 2023 -211.72%
Sep 30, 2023 -229.27%
Jun 30, 2023 -162.59%
Mar 31, 2023 -112.01%
Dec 31, 2022 -83.20%
Sep 30, 2022 -64.55%
Jun 30, 2022 -54.26%
Mar 31, 2022 -43.09%
Dec 31, 2021 -37.49%
Sep 30, 2021 -30.45%
API Access

Gain Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=GANX&period=max&api_key=YOUR_API_KEY